- Global Pharma News & Resources

HumanOptics AG: CE-marking for innovative trifocal lens TRIVA(R)

DGAP-News: HumanOptics AG / Key word(s): Miscellaneous
19.02.2020 / 16:39
The issuer is solely responsible for the content of this announcement.

HumanOptics: CE-marking for innovative trifocal lens TRIVA(R)

Erlangen, 18 February 2020 - HumanOptics AG has received CE marking and thus approval on the European market for its new trifocal lens TRIVA-aA. With this innovative intraocular lens (IOL), the specialist for high-quality ophthalmic surgery implants is expanding its range in the rapidly growing premium lens segment.

TRIVA-aA is the first multifocal lens from HumanOptics with three focal points. Its optimized design enables patients to enjoy good vision not only at long and near distances, but also at medium distances. It is therefore particularly suitable for screen work or the use of tablets and smartphones and is tailored to the requirements of a modern, digital living environment in today's society.

The novel lens is used in cataract surgery, which is becoming increasingly important due to demographic developments. Cataract surgery is getting an increasingly refractive character, which means that in addition to cataracts, ametropia is also corrected.

The novel trifocal lenses are produced with high-precision sub-nano resolution (SNR) technology in Germany. This technology, which can only be realized by using appropriate ultra-precision lathes and makes subsequent polishing superfluous, makes HumanOptics the world leader.

Company profile:

HumanOptics AG ( specializes in the development, production and sale of high-quality implants and accessories for ophthalmic surgery and stands for the highest quality and innovative strength in this segment. The most important products are intraocular lenses (IOL) for the treatment of cataracts and various forms of ametropia as well as artificial irises. In addition, the company offers the operating ophthalmologists accessories and complementary products as well as comprehensive consulting services. The shares of HumanOptics AG are listed on the Basic Board of the Frankfurt Stock Exchange.

Contact us:

HumanOptics AG
Investor Relations
Spardorfer Str. 150
91054 Erlangen
Phone: +49 (0) 9131 50665-0

19.02.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

Language: English
Company: HumanOptics AG
Spardorfer Str. 150
91054 Erlangen
Phone: +49 (0)9131 - 50665-60
Fax: +49 (0)9131 - 50665-93
ISIN: DE000A1MMCR6, DE000A255FK8
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Stuttgart
EQS News ID: 979341

End of News DGAP News Service

Editor Details

Last Updated: 19-Feb-2020